Drawing for URIS

USPTO serial 79430358

URIS

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
KRUSSMAN, IAN GEORGE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with URIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cathleen E. Stadecker

Cathleen E. Stadecker Downs Rachlin Martin PLLC199 Main Street, PO Box 190Burlington, VT 05402United States

Goods and services

ClassDescriptionStatusFirst use
009Electrodes and devices for neurostimulation for scientific and research purposes; Downloadable and recorded computer software for use in the design and use of medical instruments and devices used in neuromodulation and electroceuticals treatment and therapyACTIVE—
010Medical apparatus and instruments used for neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Medical devices used for neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Electrodes for medical use used for neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Medical electrodes and medical devices for use in neuromodulation, electro-stimulation and electroceuticals treatment and therapy; Medical instruments and devices for use in electroceuticals and neuromodulation treatment and therapy; Medical devices, namely, pulse generators for neurostimulationACTIVE—
042Design, engineering, research, development and testing services for medical, scientific and technological products in the field of neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Design and development of medical instruments and devices for use in neuromodulation and electroceuticals treatment and therapy; Technology research in the field of medical instruments and devices for use in neuromodulation and electroceuticals treatment and therapy; Medical and scientific research services in the field of neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Medical and scientific research in the fields of urology, neurology, gynecology, infertility, overactive bladder, neurodegenerative diseases, and chronic diseases using neuromodulation and electroceuticals treatment and therapy; Providing medical and scientific research information in the fields of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Research and development of technology in the field of healthcare and medical devices, namely, in the field of neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Development of technology in the field of medical instruments and devices for neuromodulation and electroceuticals treatment and therapy; Design and development of computer software; Software as a service (SAAS) services featuring software for use in the design and use of medical instruments and devices used in neuromodulation and electroceuticals treatment and therapy; Providing temporary use of on-line non-downloadable software for use in the design and use of medical instruments and devices used in neuromodulation and electroceuticals treatment and therapyACTIVE—
044Medical services in the field of neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Healthcare services in the nature of neuromodulation and electroceuticals treatment in the field of urology, neurology, gynecology, infertility, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; Medical services in the fields of urology, neurology, gynecology, infertility, neurodegenerative diseases, overactive bladder, and chronic diseases using electroceuticals and neuromodulation treatment and therapy; Medical consultancy; Providing medical information in the fields of urology, neurology, gynecology, infertility, neurodegenerative diseases, overactive bladder, and chronic diseases using electroceuticals and neuromodulation treatment and therapy; Medical treatment of low urinary tract disfunction, Parkinson's diseases, Alzheimer's diseases, bowel disfunction, epilepsy, migraine and infertility using electroceuticals and neuromodulation treatment and therapy; Rental of medical instruments and devices for use in electroceuticals and neuromodulation therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 18, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 28, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 28, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Oct 28, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 28, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 15, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 15, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 15, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 14, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 14, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 14, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2026RFNTREFUSAL PROCESSED BY IB—
Mar 6, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 6, 2026RFRRREFUSAL PROCESSED BY MPU—
Feb 6, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 5, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2026DOCKASSIGNED TO EXAMINER—
Jan 30, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 30, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 12, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 14, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance